More than 100 of KFDA drug registration reviews being disclosed.

Published: 2006-08-11 06:59:00

Updated: 2006-08-11 06:59:00

The disclosure policy of the new drug registration review outcomes has been implemented since 2004, which was recently more accelerated, expecting to give a lot of helps for the drug makers to get the same registration.

The disclosure policy has come along with the introduction movement of the...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK